应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02228 晶泰控股
交易中 03-18 15:49:31
10.050
+0.090
+0.90%
最高
10.170
最低
9.800
成交量
4,010万
今开
10.000
昨收
9.960
日振幅
3.71%
总市值
432.45亿
流通市值
432.45亿
总股本
43.03亿
成交额
4.01亿
换手率
0.93%
流通股本
43.03亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | 晶泰控股(02228)现涨超4% 2025年度首次盈利 稀缺AI制药平台价值加速兑现
智通财经 · 03-16 14:27
港股异动 | 晶泰控股(02228)现涨超4% 2025年度首次盈利 稀缺AI制药平台价值加速兑现
每日卖空追踪 | 晶泰控股 03月11日卖空量成交94.8万股,卖空比例为3.2%
市场透视 · 03-11
每日卖空追踪 | 晶泰控股 03月11日卖空量成交94.8万股,卖空比例为3.2%
晶泰控股03月11日主力净流出1637.8万元 散户资金买入
市场透视 · 03-11
晶泰控股03月11日主力净流出1637.8万元 散户资金买入
晶泰控股(02228)委任周斐然为首席财务官
智通财经 · 03-10
晶泰控股(02228)委任周斐然为首席财务官
晶泰控股03月10日主力净流入941.4万元 散户资金抛售
市场透视 · 03-10
晶泰控股03月10日主力净流入941.4万元 散户资金抛售
每日卖空追踪 | 晶泰控股 03月09日卖空量成交804.7万股,卖空比例为10.64%
市场透视 · 03-09
每日卖空追踪 | 晶泰控股 03月09日卖空量成交804.7万股,卖空比例为10.64%
国泰海通:AI制药持续进展 跨国药企布局加速
智通财经 · 03-09
国泰海通:AI制药持续进展 跨国药企布局加速
【券商聚焦】西南证券:晶泰控股(2228.HK)AI驱动创新,首次覆盖建议关注
金吾财讯 · 03-09
【券商聚焦】西南证券:晶泰控股(2228.HK)AI驱动创新,首次覆盖建议关注
晶泰控股盘中异动 早盘大幅跳水5.17%报9.540港元
市场透视 · 03-09
晶泰控股盘中异动 早盘大幅跳水5.17%报9.540港元
【券商聚焦】交银国际:医药公司业绩兑现有望催化板块行情
金吾财讯 · 03-06
【券商聚焦】交银国际:医药公司业绩兑现有望催化板块行情
每日卖空追踪 | 晶泰控股 03月05日卖空量成交473.5万股,卖空比例为9.05%
市场透视 · 03-05
每日卖空追踪 | 晶泰控股 03月05日卖空量成交473.5万股,卖空比例为9.05%
纽曼思(02530)购入总共200万股晶泰科技股份
智通财经 · 03-04
纽曼思(02530)购入总共200万股晶泰科技股份
晶泰控股(02228)2026年2月股份变动月报表,股本维持稳定
公告速递 · 03-04
晶泰控股(02228)2026年2月股份变动月报表,股本维持稳定
港股公告掘金 | 创科实业2025年净利同比增长6.8%至12亿美元 末期息每股132港仙
智通财经 · 03-04
港股公告掘金 | 创科实业2025年净利同比增长6.8%至12亿美元 末期息每股132港仙
潮水退去,谁才是港股AI应用之王?
智通财经 · 03-03
潮水退去,谁才是港股AI应用之王?
晶泰控股有限公司2025财年营收预计7.80亿元,净利润1.00亿元
公告速递 · 03-03
晶泰控股有限公司2025财年营收预计7.80亿元,净利润1.00亿元
晶泰控股(02228)发盈喜 预期2025年税后溢利及公司权益持有人应占利润均不少于1亿元 首次实现全年盈利
智通财经 · 03-03
晶泰控股(02228)发盈喜 预期2025年税后溢利及公司权益持有人应占利润均不少于1亿元 首次实现全年盈利
每日卖空追踪 | 晶泰控股 03月03日卖空量成交333.3万股,卖空比例为4.45%
市场透视 · 03-03
每日卖空追踪 | 晶泰控股 03月03日卖空量成交333.3万股,卖空比例为4.45%
【券商聚焦】招银国际:AI将改变创新药物研发范式
金吾财讯 · 03-02
【券商聚焦】招银国际:AI将改变创新药物研发范式
【券商聚焦】交银国际:2026年医药板块稳中向好态势或将延续 但仍有短期波动可能
金吾财讯 · 02-27
【券商聚焦】交银国际:2026年医药板块稳中向好态势或将延续 但仍有短期波动可能
加载更多
公司概况
公司名称:
晶泰控股
所属市场:
SEHK
上市日期:
--
主营业务:
晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":10.05,"timestamp":1773820168447,"preClose":9.96,"halted":0,"volume":40095010,"delay":0,"changeRate":0.009036144578313239,"floatShares":4303000000,"shares":4303000000,"eps":-0.9005030218940338,"marketStatus":"交易中","change":0.09,"latestTime":"03-18 15:49:31","open":10,"high":10.17,"low":9.8,"amount":401038052,"amplitude":0.037149,"askPrice":10.05,"askSize":21000,"bidPrice":10.04,"bidSize":57000,"shortable":3,"etf":0,"ttmEps":-0.05699386214519201,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1773821400000},"marketStatusCode":2,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":9.96,"openAndCloseTimeList":[[1773797400000,1773806400000],[1773810000000,1773820800000]],"volumeRatio":0.811559,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02228","defaultTab":"news","newsList":[{"id":"2619348894","title":"港股异动 | 晶泰控股(02228)现涨超4% 2025年度首次盈利 稀缺AI制药平台价值加速兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2619348894","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619348894?lang=zh_cn&edition=full","pubTime":"2026-03-16 14:27","pubTimestamp":1773642425,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,晶泰控股现涨超4%,截至发稿,涨4%,报9.88港元,成交额3.83亿港元。消息面上,晶泰控股此前发布盈喜,预计公司2025年度实现营收不少于7.8亿元,同比增长超193%;归母净利润不少于1亿元,同比扭亏为盈,首次实现全年盈利。国联民生发布研报称,2025年业绩亮眼,稀缺AI制药平台价值加速兑现。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3923f54d12d0c12982608f5f8a99e8da","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414227.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","01477","BK4585","BK4588","BK1191","BK1617","BK1141","02228","VXUS"],"gpt_icon":0},{"id":"2618979251","title":"每日卖空追踪 | 晶泰控股 03月11日卖空量成交94.8万股,卖空比例为3.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618979251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618979251?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217829,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间03月11日,跌1.2%,卖空量成交94.8万股,较上一交易日减少85.3%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163353a6b794f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163353a6b794f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2618979298","title":"晶泰控股03月11日主力净流出1637.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618979298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618979298?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:16","pubTimestamp":1773216961,"startTime":"0","endTime":"0","summary":"03月11日, 晶泰控股股价跌1.20%,报收9.90元,成交金额3.0亿元,换手率0.69%,振幅2.59%,量比0.44。晶泰控股今日主力资金净流出1637.8万元,上一交易日主力净流入941.4万元。该股近5个交易日上涨3.24%,主力资金累计净流入1162.3万元;近20日主力资金累计净流出1.7亿元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162134a460ac60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162134a460ac60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2618193105","title":"晶泰控股(02228)委任周斐然为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2618193105","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618193105?lang=zh_cn&edition=full","pubTime":"2026-03-10 18:54","pubTimestamp":1773140068,"startTime":"0","endTime":"0","summary":"智通财经APP讯,晶泰控股(02228)公布,周斐然先生由2026年3月10日起获委任为公司首席财务官。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2618915325","title":"晶泰控股03月10日主力净流入941.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2618915325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618915325?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:15","pubTimestamp":1773130547,"startTime":"0","endTime":"0","summary":"03月10日, 晶泰控股股价涨2.87%,报收10.02元,成交金额5.3亿元,换手率1.25%,振幅3.18%,量比0.75。晶泰控股今日主力资金净流入941.4万元,上一交易日主力净流出2092.0万元。该股近5个交易日上涨5.24%,主力资金累计净流出563.1万元;近20日主力资金累计净流出1.4亿元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310161909a6b4c7f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310161909a6b4c7f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"2618620120","title":"每日卖空追踪 | 晶泰控股 03月09日卖空量成交804.7万股,卖空比例为10.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618620120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618620120?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045029,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间03月09日,跌3.18%,卖空量成交804.7万股,较上一交易日减少8.5%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163349a6b1c77f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163349a6b1c77f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228","BK1617"],"gpt_icon":0},{"id":"2618461976","title":"国泰海通:AI制药持续进展 跨国药企布局加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2618461976","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618461976?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:21","pubTimestamp":1773044509,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,国泰海通发布研报称,随着AI在靶点发现、分子生成、临床设计及上市后数据分析中的全面渗透,行业渗透率持续提升,AI+制药正成为创新药研发的重要基础设施。国泰海通主要观点如下:AI+制药重塑研发范式,行业从概念迈入实效验证期生成式模型与强化学习的深度融合,显著提升分子设计效率,缩短研发周期。整体来看,AI正在成为药物研发体系升级的核心变量。在人工智能与医药双领域共振下,看好AI+制药发展前景。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0201","BK1564","01873","601211","BK0188","03696","01477","BK1191","BK0184","BK0012","02228","BK1576","BK0276","BK1141","BK0183","BK0028","02611","BK1617","BK1147","BK1574"],"gpt_icon":0},{"id":"2618124620","title":"【券商聚焦】西南证券:晶泰控股(2228.HK)AI驱动创新,首次覆盖建议关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2618124620","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618124620?lang=zh_cn&edition=full","pubTime":"2026-03-09 11:59","pubTimestamp":1773028744,"startTime":"0","endTime":"0","summary":"金吾财讯|西南证券发布研报指,晶泰控股当前价9.54港元,作为AI for Science核心标的,近期实现跨越式进展。行业层面,全球AI药物研发企业超900家,TOP20药企均布局AI研发管线。药物发现外包市场增速显著,2023-2030年全球CAGR 14.9%,中国达19.6%。个股方面,公司量子物理+AI+机器人三位一体平台覆盖小分子、抗体等全链条研发,XtalFold抗体平台准确率提升10%。风险提示创新药商业化及政策变化风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309120850a6b10e05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309120850a6b10e05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141","BK1617"],"gpt_icon":0},{"id":"2618361996","title":"晶泰控股盘中异动 早盘大幅跳水5.17%报9.540港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618361996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618361996?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:31","pubTimestamp":1773019883,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时31分,晶泰控股股票出现异动,股价快速下跌5.17%。截至发稿,该股报9.540港元/股,成交量359.8万股,换手率0.08%,振幅1.99%。资金方面,该股资金流入1106.26万港元,流出1447.23万港元。晶泰控股股票所在的生物技术行业中,整体跌幅为1.93%。其相关个股中,科济药业-B、派格生物医药-B、维立志博-B涨幅较大,振幅较大的相关个股有科济药业-B、药捷安康-B、派格生物医药-B,振幅分别为15.55%、9.51%、8.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093123a459a1b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093123a459a1b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"2617919503","title":"【券商聚焦】交银国际:医药公司业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617919503","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617919503?lang=zh_cn&edition=full","pubTime":"2026-03-06 09:08","pubTimestamp":1772759313,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报,2026年以来,内资通过港股通持有医药股的比例呈现先降后升态势,当前水平与年初持平,外资持仓则有所提升。本周内资继续加仓创新药产业链和器械标的,外资则重点布局创新药企及CXO企业。年报季临近,本周各公司业绩预告陆续发布,该机构建议持续关注财务表现超预期、盈利路径清晰的公司,其业绩兑现有望催化板块行情。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976027","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","LU2476274720.SGD","SG9999014674.SGD","02268","LU1961090484.USD","09688","BK1585","SG9999004311.SGD","02196","LU2488822045.USD","LU2399975544.HKD","BK1593","BK1141","LU0588546209.SGD","02228","BK1207","LU0640798160.USD","LU1115378108.SGD","BK1191","LU0417516571.SGD","02367","LU2476274308.USD","03933","LU1770034418.SGD","03329","01789","BK1574","LU0561508036.HKD","LU2778985437.USD","09939","BK1197","LU0348766576.USD","LU1719994722.HKD","159938","LU0348825331.USD","09926","LU1794554557.SGD","01099","BK1515","LU0348783233.USD","LU0348784397.USD","LU0348827113.USD","LU0348735423.USD","LU0540923850.HKD","LU1303224171.USD","LU2328871848.SGD","06160","01530","HK0000165453.HKD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2617210523","title":"每日卖空追踪 | 晶泰控股 03月05日卖空量成交473.5万股,卖空比例为9.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617210523","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617210523?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699429,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间03月05日,涨1.67%,卖空量成交473.5万股,较上一交易日减少62.1%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163354a44ef7ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163354a44ef7ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","BK1141","02228"],"gpt_icon":0},{"id":"2616531436","title":"纽曼思(02530)购入总共200万股晶泰科技股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2616531436","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616531436?lang=zh_cn&edition=full","pubTime":"2026-03-04 19:05","pubTimestamp":1772622310,"startTime":"0","endTime":"0","summary":"智通财经APP讯,纽曼思(02530)发布公告,于2026年3月4日,本集团于公开市场以总代价1973万港元(包括印花税及相关开支)购入总共200万股晶泰科技股份。购入事项的总代价由本集团的内部资源以现金悉数支付。董事确认,该代价并非以本公司首次公开发售所得款项支付。所购入的晶泰科技200万股股份的平均购买价约为每股9.86港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","02228","BK1207","BK1141","02530"],"gpt_icon":0},{"id":"1193654326","title":"晶泰控股(02228)2026年2月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1193654326","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193654326?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:53","pubTimestamp":1772614409,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司于2026年3月4日发布2026年2月股份变动月报表,公司授权股本维持在100,000,000,000股,面值每股USD 0.00001,总额为USD 1,000,000。截至2026年2月28日,普通股已发行股数为4,303,371,761股,较上月无新增发行或回购注销,库存股份数为零。公司另设“首次公开发售后购股权计划”和“首次公开发售后受限制股份单位计划”,截至2026年2月28日,可能发行或转让的普通股数量分别为202,606,365股和1,350,000股,未见最新变动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"gpt_icon":0},{"id":"2616865309","title":"港股公告掘金 | 创科实业2025年净利同比增长6.8%至12亿美元 末期息每股132港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2616865309","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616865309?lang=zh_cn&edition=full","pubTime":"2026-03-04 09:15","pubTimestamp":1772586900,"startTime":"0","endTime":"0","summary":"【重大事项】中国生物制药(01177)与Sanofi就罗伐昔替尼订立独家授权协议德琪医药-B(06996)与优时比就ATG-201达成全球独家授权协议固生堂(02273)拟收购济南新阳光、济南蕴生堂及济南历城蕴生堂各70%股权俊知集团(01300)预中标中国电信电力电缆(2025年– 2027年)集中采购项目兆易创新(03986)拟出资4亿元认购上海石溪兆易智芯创业投资合伙企业(有限合伙)金山云(","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409752.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B0169N27.USD","LU1119993845.HKD","IE00BYTNYN87.SGD","02228","BK1534","00041","IE00B12V2V27.USD","IE0008368411.USD","IE0034224299.USD","LU0261947096.USD","BK1216","VT","IE00B031J352.USD","IE0031814852.USD","LU0877626530.USD","BK1592","BK1141","LU2488822045.USD","01112","IE0008368742.USD","IE00B031HY20.USD","IE0008369823.USD","VXUS","BK1617","LU0048388663.USD","BK1190","LU0251144936.SGD","LU2125910500.SGD","LU2242644610.SGD","LU0205439572.USD","BK1183","LU0327786744.USD","LU1102505762.USD","LU2008162690.USD","BK1521","IE0009570106.USD","LU0572944931.SGD","01208","LU0229945570.USD","BK1597","LU2045819591.USD","LU0607220059.USD","BK1553","LU0106259558.USD","SG9999014674.SGD","00669","BK4588","LU2177674079.SGD","IE00B031HW06.USD","BK1237"],"gpt_icon":0},{"id":"2616329855","title":"潮水退去,谁才是港股AI应用之王?","url":"https://stock-news.laohu8.com/highlight/detail?id=2616329855","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616329855?lang=zh_cn&edition=full","pubTime":"2026-03-03 22:36","pubTimestamp":1772548591,"startTime":"0","endTime":"0","summary":"开年以来,港股AI应用板块持续升温,成为资本市场关注的焦点。多位国家领导人反复莅临晶泰,彰显了国家对于AI应用产业落地的支持决心。凭借完整的技术体系、稳健的经营能力、前瞻的业务布局以及雄厚的资金储备,这家聚焦AI医药与AI for Science赛道的企业,已初步显露港股AI应用“王者”的气质。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VT","VXUS","BK4588","02228","BK4585","BK1141","BK1617"],"gpt_icon":0},{"id":"1100742520","title":"晶泰控股有限公司2025财年营收预计7.80亿元,净利润1.00亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100742520","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100742520?lang=zh_cn&edition=full","pubTime":"2026-03-03 18:05","pubTimestamp":1772532357,"startTime":"0","endTime":"0","summary":"根据公告披露,晶泰控股有限公司预计截至2025年12月31日止年度将实现全年扭亏为盈。公告显示,公司2024财年的收入约为2.66亿元,净亏损约15.15亿元;而在2025财年,公司收入将不低于7.80亿元,同比增长约193%,净利润预计不少于1.00亿元,较去年明显扭转亏损局面。同时,2025财年由按公允价值计入损益的金融资产带来的收益净额将达到5.00亿元,远高于2024财年的0.25亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"gpt_icon":0},{"id":"2616345526","title":"晶泰控股(02228)发盈喜 预期2025年税后溢利及公司权益持有人应占利润均不少于1亿元 首次实现全年盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2616345526","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616345526?lang=zh_cn&edition=full","pubTime":"2026-03-03 18:03","pubTimestamp":1772532239,"startTime":"0","endTime":"0","summary":"智通财经APP讯,晶泰控股 公布,该集团预期于2025年的税后溢利及公司权益持有人应占利润均不少于人民币1亿元,同比扭亏为盈,首次实现全年盈利。公司于2024财年取得可转换可赎回优先股公允价值亏损约人民币8.754亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"晶泰控股(02228)发盈喜 预期2025年税后溢利及公司权益持有人应占利润均不少于1亿元 首次实现全年盈利","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","BK1141","BK1617"],"gpt_icon":0},{"id":"2616246347","title":"每日卖空追踪 | 晶泰控股 03月03日卖空量成交333.3万股,卖空比例为4.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616246347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616246347?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:30","pubTimestamp":1772526630,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间03月03日,跌2.05%,卖空量成交333.3万股,较上一交易日减少37.97%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163357a69caba1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163357a69caba1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228","BK1617"],"gpt_icon":0},{"id":"2616538865","title":"【券商聚焦】招银国际:AI将改变创新药物研发范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2616538865","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616538865?lang=zh_cn&edition=full","pubTime":"2026-03-02 14:40","pubTimestamp":1772433633,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示,MSCI中国医疗指数2026年初至今累计上涨5.0%,跑赢MSCI中国指数6.2%。医药行业近期明显回调(MSCI中国医疗指数1月15日至今累计下跌9%),特别是创新药板块回调幅度较大(恒生生物科技指数1月15日至今累计下跌13%)。该机构认为,此轮调整原因包括博弈层面行业短期缺乏催化剂,以及行业轮动导致资金流出医药板块。中国创新药资产出海BD持续超预期,MNC对于中国资产的购买范围从单个管线拓宽至平台合作,进一步体现了中国创新药的竞争力。该机构认为,中国的AI制药技术发展迅猛,将涌现一批优秀的创新企业。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975709","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1961090484.USD","BK1161","02268","LU0348783233.USD","BK1207","LU2488822045.USD","01099","LU1251922891.USD","LU0348825331.USD","159992","LU0348827113.USD","BK1617","LU2328871848.SGD","01530","IE00BPRC5H50.USD","LU1115378108.SGD","BK1583","BK1585","09926","LU1794554557.SGD","LU1720050803.USD","BK1197","BK1141","HK0000165453.HKD","LU0348735423.USD","02367","BK1515","BK1574","IE00B5MMRT66.SGD","LU0588546209.SGD","LU2399975544.HKD","02196","SG9999004311.SGD","LU2476274720.SGD","LU0640798160.USD","03933","LU0634319403.HKD","LU1969619763.USD","LU0561508036.HKD","SG9999014674.SGD","09688","IE00B543WZ88.USD","06160","06978","02228","LU0307460666.USD","LU1303224171.USD","LU0348784397.USD","BK1100","01789"],"gpt_icon":0},{"id":"2614009267","title":"【券商聚焦】交银国际:2026年医药板块稳中向好态势或将延续 但仍有短期波动可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009267","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614009267?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:45","pubTimestamp":1772156713,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报,本周2026ASCOGU大会常规摘要公布,此次大会将于本月2628号召开,共有超过70项我国专家主导的研究入选,荣昌、翰森、科伦博泰、映恩生物等中国创新药企将携重磅数据亮相,临床数据密集释放有望阶段性催化板块行情。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975588","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","BK1197","LU0348766576.USD","LU2778985437.USD","LU2488822045.USD","LU0634319403.HKD","BK1617","03329","BK1100","09939","01789","LU0640798160.USD","02228","LU2476274308.USD","02367","LU0348825331.USD","BK1141","BK1588","LU0348827113.USD","LU2399975544.HKD","BK1207","BK1191","02268","LU1251922891.USD","LU0348784397.USD","LU2476274720.SGD","LU0417516738.SGD","02196","03933","LU0348767384.USD","LU1720050803.USD","LU0417516571.SGD","LU1770034418.SGD","06160","09688","SG9999014674.SGD","IE00BPRC5H50.USD","159938","BK1147","BK1161","BK1515","LU0540923850.HKD","IE00B543WZ88.USD","LU1794554557.SGD","HK0000165453.HKD","01099","LU1961090484.USD","LU0588546209.SGD","01530","09926"],"gpt_icon":0}],"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":-0.1115},{"period":"3month","weight":0.0756},{"period":"6month","weight":-0.0621},{"period":"1year","weight":0.491},{"period":"ytd","weight":0.0529}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.0263},{"period":"3month","weight":0.0157},{"period":"6month","weight":-0.0255},{"period":"1year","weight":0.0714},{"period":"ytd","weight":0.0093}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"晶泰控股","nameEN":"XTALPI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晶泰控股,02228,晶泰控股股票,晶泰控股股票老虎,晶泰控股股票老虎国际,晶泰控股行情,晶泰控股股票行情,晶泰控股股价,晶泰控股股市,晶泰控股股票价格,晶泰控股股票交易,晶泰控股股票购买,晶泰控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}